*
Corresponding authors
a
Department of Medicinal Chemistry, Gilead Sciences Inc, 333 Lakeside Drive, Foster City, CA, USA
E-mail:
lianhong.xu@gilead.com.
b
Department of Biology, Gilead Sciences Inc, 333 Lakeside Drive, Foster City, CA, USA
c
Department of Drug Metabolism, Gilead Sciences Inc, 333 Lakeside Drive, Foster City, CA, USA
d
Department of Structural Chemistry, Gilead Sciences Inc, 333 Lakeside Drive, Foster City, CA, USA
e
Department of Formulation, Gilead Sciences Inc, 333 Lakeside Drive, Foster City, CA, USA
f
Gilead Research, Gilead Sciences Inc, 333 Lakeside Drive, Foster City, CA, USA